A Real-World Evaluation of Health-Related Quality of Life Using the EQ-5D-5L Instrument in Patients Undergoing Radiotherapy for Prostate Cancer [0.03%]
放射治疗前列腺癌患者利用EQ-5D-5L工具进行的健康相关生活质量实证研究评估
Tanja Sprave,Simon Fauser,Petros Paplomatas et al.
Tanja Sprave et al.
Background/aim: Prostate cancer (PC) is increasingly treated with curative intent, making health-related quality of life (HRQOL) a key outcome. This prospective study evaluated the EQ-5D-5L instrument based HRQOL trajecto...
Diuretic Administration for Vomiting During Concurrent Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study [0.03%]
降水分组在同步放化疗期间治疗宫颈癌呕吐的多中心回顾性研究
Naoya Tonomura,Kensuke Yoshida,Hajime Morita et al.
Naoya Tonomura et al.
Background/aim: Chemotherapy-induced nausea and vomiting (CINV) remain major challenges during concurrent chemoradiotherapy (CCRT) for cervical cancer. Mannitol and furosemide are agents widely used to prevent cisplatin-i...
Multicenter Study
Anticancer research. 2026 Mar;46(3):1497-1506. DOI:10.21873/anticanres.18044 2026
Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications [0.03%]
PSMB9在肝细胞癌免疫活化和肿瘤适应中的双重作用及其治疗和预后意义
Yiting Liu,Jiaojiao Cao,Haiyang Yu et al.
Yiting Liu et al.
Background/aim: Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy with poor prognosis. Although multiple treatment modalities are available, reliable biomarkers to stratify tumor immune status and guide ...
Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status [0.03%]
基于CPS状态的老年头颈部癌患者使用帕博利珠单抗单一疗法的疗效分析
Yuri Ueda,Takuro Okada,Isaku Okamoto et al.
Yuri Ueda et al.
Background/aim: The first-line treatment for platinum-sensitive recurrent or metastatic head and neck cancer (R/M HNSCC) is pembrolizumab with or without chemotherapy. The decision to combine chemotherapy largely depends ...
Clinical Significance of LRG1 Protein Expression in Locally Advanced Gastric Cancer After Curative Resection [0.03%]
完全切除的局部晚期胃癌患者LRG1蛋白表达的意义
Hayato Watanabe,Tomoko Jitsukata,Yukihiko Hiroshima et al.
Hayato Watanabe et al.
Background/aim: Leucine-rich α2-glycoprotein-1 (LRG1), a secreted glycoprotein involved in inflammation, angiogenesis, and tumor progression, has been proposed as a biomarker in several malignancies. However, its clinica...
Long-term Outcomes and Functional Limitations of Liquid Nitrogen-treated Autografts in Limb Salvage Surgery for Bone Malignancies [0.03%]
液氮处理的自体骨移植救治骨恶性肿瘤保肢手术远期疗效及功能障碍分析
Masanori Kawano,Yuta Kubota,Ichiro Itonaga et al.
Masanori Kawano et al.
Background/aim: Liquid nitrogen-treated autografts are increasingly used in limb-salvage surgery because they preserve bone strength, maintain biological activity, and may enhance antitumor immunity. However, the true cli...
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study [0.03%]
结直肠和间皮瘤腹膜转移细胞减灭术及术后超温腹腔内化学治疗12年疗效分析
Harleen Kaur,Gershwin Isaac Singh Bhall,Christopher Lauder et al.
Harleen Kaur et al.
Background/aim: Peritoneal surface malignancies, including colorectal peritoneal metastases (CRPM) and peritoneal mesothelioma (PM) carry poor prognoses. The advent of cytoreductive surgery (CRS) and hyperthermic intraper...
Evaluation of the Validity of Pancreatoduodenectomy for Elderly Patients With Ampullary Carcinoma from the Perspective of Nutritional Status at Recurrence [0.03%]
从复发时营养状况角度评估老年十二指肠乳头癌患者施行胰十二指肠切除术的合理性分析
Wataru Izumo,Ryo Saito,Hidetake Amemiya et al.
Wataru Izumo et al.
Background/aim: Although, the number of pancreatoduodenectomy for elderly patients is increasing, the significance of pancreatoduodenectomy for long-term prognosis in elderly patients remains unclear. To clarify the valid...
Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights [0.03%]
替雷利姆单抗/度伐利尤单抗一线治疗不可切除肝细胞癌的临床效用：血清细胞因子谱系的见解
Kunihide Mohri,Hidenari Nagai,Takanori Mukozu et al.
Kunihide Mohri et al.
Background/aim: Although immunotherapies such as atezolizumab plus bevacizumab (Ate/Bev) and tremelimumab plus durvalumab (Tre/Dur) are recommended as first-line treatments for unresectable hepatocellular carcinoma (uHCC)...
Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy [0.03%]
评估仑伐替尼治疗的真实世界尿蛋白肌酐比和血压分析
Masanari Tsuji,Kazuo Kobayashi,Kazuyoshi Kawakami et al.
Masanari Tsuji et al.
Background/aim: Lenvatinib is widely used to treat several malignancies. Proteinuria is a frequent adverse event associated with lenvatinib; however, limited evidence exists regarding risk factors for severe proteinuria-s...